Perinatal collagen turnover markers in intrauterine growth restriction

Objective: To investigate bone and connective tissue collagen turnover in intrauterine growth restricted (IUGR) pregnancies, by determining circulating markers of type I collagen synthesis (carboxy-terminal propeptide of type I procollagen [PICP], representing bone formation) and degradation (cross-linked telopeptide of type I collagen [ICTP], representing bone resorption) as well as type III collagen synthesis (N-terminal propeptide of type-III procollagen [PIIINP], reflecting growth and tissue maturity).Methods: Plasma PICP, ICTP and PIIINP concentrations were measured in 40 mothers and their 20 asymmetric IUGR and 20 appropriate for gestational age (AGA) full-term fetuses and neonates on postnatal day 1-(N1) and 4-(N4).Results: Fetal PICP, fetal and N4 ICTP, as well as fetal, N1 and N4 PIIINP concentrations were higher in the IUGR group (p ≤ 0.038, in all cases). In both groups, maternal PICP, ICTP and PIIINP concentrations were lower than fetal, N1 and N4 ones (p < 0.001, in each case).Conclusions: Type I collagen turnover is enhanced in IUGR than AGA fetuses/neonates. Similarly, fetal/neonatal PIIINP concentrations are elevated in IUGR, probably due to stress, responsible for induction of tissue maturation, and/or to impaired excretory renal function, leading to reduced protein clearance. Fetal/neonatal PICP, ICTP and PIIINP concentrations are higher than maternal concentrations, possibly reflecting increased skeletal growth and collagen turnover in the former.

[1]  Kivirikko Ki.  Biosynthesis of collagen and its disorders , 2010 .

[2]  H. Torrance,et al.  Lung maturation in small for gestational age fetuses from pregnancies complicated by placental insufficiency or maternal hypertension. , 2008, Early human development.

[3]  G. Creatsas,et al.  Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction. , 2008, Bone.

[4]  M. Kalmanti,et al.  Levels of bone collagen markers in preterm infants: relation to antenatal glucocorticoid treatment , 2007, Journal of Bone and Mineral Metabolism.

[5]  R. Zimmermann,et al.  Reference values for the weight of freshly delivered term placentas and for placental weight-birth weight ratios. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[6]  H. Delemarre-van de Waal,et al.  Consequences of Intrauterine Growth Restriction for the Kidney , 2006, Kidney and Blood Pressure Research.

[7]  T. Nakayama,et al.  High bone turnover of type I collagen depends on fetal growth. , 2006, Bone.

[8]  A. Baschat,et al.  Doppler and biophysical assessment in growth restricted fetuses: distribution of test results , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[9]  J. Risteli,et al.  Products of Bone Collagen Metabolism , 2006 .

[10]  F. Mimouni,et al.  Bone Ultrasound Velocity of Infants Born Small for Gestational Age , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[11]  T. Wilsgaard,et al.  Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. , 2005, American journal of obstetrics and gynecology.

[12]  R. Tsang,et al.  Bone in the pregnant mother and newborn at birth. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[13]  P. Taylor,et al.  The Fetal Origins of Osteoporotic Fracture , 2002, Calcified Tissue International.

[14]  J. Seckl.  Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms , 2001, Molecular and Cellular Endocrinology.

[15]  E. Kajantie,et al.  Markers of Type I and Type III Collagen Turnover, Insulin-Like Growth Factors, and Their Binding Proteins in Cord Plasma of Small Premature Infants: Relationships with Fetal Growth, Gestational Age, Preeclampsia, and Antenatal Glucocorticoid Treatment , 2001, Pediatric Research.

[16]  R. Sorva,et al.  Markers of collagen metabolism and insulin-like growth factor binding protein-1 in term infants , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[17]  R. Tsang,et al.  Factors affecting newborn bone mineral content: in utero effects on newborn bone mineralization , 2000, Proceedings of the Nutrition Society.

[18]  M. Taga,et al.  Comparison of Bone Metabolic Markers between Maternal and Cord Blood , 1999, Hormone Research in Paediatrics.

[19]  N. McIntosh,et al.  Bone and Collagen Markers in Preterm Infants: Relationship with Growth and Bone Mineral Content over the First 10 Weeks of Life , 1999, Pediatric Research.

[20]  J. Studd,et al.  The relationship of fetal serum markers of bone metabolism to gestational age. , 1998, Early human development.

[21]  S. Mora,et al.  Bone turnover in neonates: changes of urinary excretion rate of collagen type I cross-linked peptides during the first days of life and influence of gestational age. , 1997, Bone.

[22]  Jensen Lt.  The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology. , 1997 .

[23]  L. T. Jensen.  The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology. , 1997, Danish medical bulletin.

[24]  R. Tsang,et al.  Normal serum indices of bone collagen biosynthesis and degradation in small for gestational age infants. , 1996, Journal of pediatric gastroenterology and nutrition.

[25]  M. Tejada,et al.  Low bone mineral density in small for gestational age infants: correlation with cord blood zinc concentrations. , 1996 .

[26]  J. Kato,et al.  Concentrations of serum markers of type I collagen synthesis and degradation and serum osteocalcin in maternal and umbilical circulation. , 1996, Endocrine journal.

[27]  P. Govaert,et al.  Aminoterminal Propeptide of Type III Procollagen in Cord Blood and Amniotic Fluid of High-Risk Pregnancies: A Biochemical Approach to the Dynamic Assessment of Deviant Fetal Growth , 1994, Pediatric Research.

[28]  J. Leroy,et al.  Aminoterminal Propeptide of Type III Procollagen in Cord Blood and Amniotic Fluid of Appropriate-for-Gestational-Age Infants: A Predictor of Age-Related Fetal Growth Rate , 1994, Pediatric Research.

[29]  J. Gardosi,et al.  Customised antenatal growth charts , 1992, The Lancet.

[30]  G. Stein,et al.  Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. , 1992, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[31]  P. Hindmarsh,et al.  Serum Concentrations of the Type I and III Procollagen Propeptides as Biochemical Markers of Growth Velocity in Healthy Infants and Children and in Children with Growth Disorders , 1991, Pediatric Research.

[32]  K. Nicolaides,et al.  Doppler study of uterine artery blood flow: comparison of findings in the first and second trimesters of pregnancy. , 1991, Fetal diagnosis and therapy.

[33]  T. Noji,et al.  N-terminal propeptide of type-III procollagen concentrations in the cord blood: an index of newborn maturity. , 1990, Biology of the neonate.

[34]  K. Kivirikko,et al.  The biosynthesis of collagen and its disorders (second of two parts). , 1979, The New England journal of medicine.

[35]  K. Kivirikko,et al.  The biosynthesis of collagen and its disorders (first of two parts). , 1979, The New England journal of medicine.